Report Description Table of Contents Enteral Feeding Devices Market Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted, Go-to-Market (GTM) Strategy, Government Regulations, Reimbursements, FDA Approvals, Supply Chain Analysis, Startup Ecosystem & Product Rating, etc. The global enteral feeding devices market will witness a robust CAGR of 6.38%, valued at $3.48 billion in 2021, expected to appreciate and reach $6.088 billion by 2030, confirms Strategic Market Research. The process of delivering complete nutritional food directly into the intestine or stomach of a patient with the help of a feeding tube is known as Enteral Feeding. According to the National Library of Medicine, the patients who receive a percutaneous feeding tube worldwide have a thirty-day mortality risk of approximately (18-24) % and a one-year mortality risk of almost (50-63)%. Among the survivors, nearly 70% of the patients showed no signs of improvement in their nutritional status. There are more than a dozen cases in the world that require tube feeding. The most common conditions that lead to the implementation of feeding tubes include malnutrition, neuromuscular and neurologic disorders, post-surgical and anatomical malformations of the oesophagus and mouth, inability to swallow, cancer, and other digestive disorders, which in turn is fuelling the market growth worldwide. According to NIS in the United States, in 2021, the patients received tube feeding in more than 250,000 hospital stays; approximately 25% of those were for newborns and children. Also, more than 400,000 American patients received this therapy from the comfort of their homes. Apart from these, early tube feeding is provided to the patients after a stroke, thereby facilitating the overall market growth. It is highly recommended that the patients start tube feeding within 24 hrs of hospitalization. All of the above-mentioned statistics are anticipated to fuel the global enteral feeding devices market during the forecasted period. The Impact of COVID-19 on the Global Market: The sudden outbreak of the COVID-19 pandemic had a positive impact on the global enteral feeding devices market. Due to this pandemic, the overall demand for eternal feeding devices worldwide has increased for providing nutritional support to patients who were critical due to COVID-19. Also, an uprise in demand for enteral feeding devices for home care purposes, including a major shift from parenteral to enteral feeding, is stimulating the overall market growth amidst these challenging situations. Enteral Feeding Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 3.48 billion The revenue forecast in 2030 USD 6.088 billion Growth rate CAGR of 6.38 % The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based on Product Type, Based on Age Group, Applications, End-User and By region. Based on Product Type Giving set, Percutaneous endoscopic gastrostomy device, Enteral feeding pumps, Low profile gastrostomy device, Gastrostomy tube, Nasogastric tube, Others Based on Age Group Children, Adult, Pediatric Based on Applications Diabetes, Cancer, Neurological Disorders, Others Based on End-User Hospitals, ASC (Ambulatory Surgical Centers), Home Care By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles Becton Dickinson, and Company., CONMED Corporation., Boston Scientific Corporation., Danone S.A., Cardinal Health Inc., Moog Inc , Cook Medical, Fresenius Kabi, Vygon Group, Nestlé S.A, B. Braun Melsungen AG. , Avanos Medical Inc., Baxter International Inc., Amsino International Inc, Omex Medical Technology, Applied Medical Technology, Danumed Medizintechnik, Fuji Systems Corporation,, Kentec Medical Inc., Medline Industries, Inc, Vesco Medical LLC, Medela Inc., Dynarex Corporation, Alcor Scientific Pricing and purchase options Customized buying options are available to meet your exact research needs. Enteral Feeding Devices Market Key Industry Drivers Leading To the Spiraling Rise in The Enteral Feeding Devices Market Is the Growth of Chronic Diseases, Growing Aging Population, Different Kinds of Feeding Tubes, Rising Awareness of Enteral Nutrition, Quality Development, Etc. The rising prevalence of chronic diseases around the globe like diabetes, cancer, and gastrointestinal diseases is one of the major factors driving this market's overall growth. According to the National Health Council, almost 133 million people (i.e., 40% of the total population) in the United States suffer from ongoing and incurable chronic diseases. Almost 50% of the adults possess a chronic condition, and nearly 8% of the children aged between 5 to 17 years have at least one chronic disease or disability. The global aging population is a significant driver for the enteral feeding devices market. Elderly individuals often experience swallowing difficulties, impaired intestinal function, or physical limitations that make oral feeding challenging. Enteral feeding devices provide a safe and adequate nutrition delivery in this population. The WHO projects that by 2050, the global population of age 60 years and above will reach 2.1 billion, increasing the demand for enteral feeding devices. Advancements in enteral feeding devices have improved their safety, ease of use, and patient comfort, driving the market growth. Innovations include the development of smaller, more flexible feeding tubes, user-friendly pump systems, and wireless communication capabilities for monitoring and control. Further, the increase in the usage of different kinds of feeding tubes such as Nasogastric tubes, Orogastric tubes, Nasoenteric tubes, Nasojejunal tubes, Jejunostomy tubes, Percutaneous endoscopic gastrostomy tube insertion, Skin level tubes, Radiologically inserted gastrostomy tube, Percutaneous endoscopic gastrostomy tubes, etc. are widely stimulating the entire market growth. Also, apart from the rising number of feeding tube usages, the advancements in the Medical tourism market (with a CAGR of 21.235%) and a huge development in the quality of G-tube insertion, Stomach tube insertion, AMT Mini One Enteral Extension Set, Gravity sets, IV pouch, and irrigation kits, Stomach tubes, enteral nutrition formulas, CO2 detectors, and Enteral syringes are widely accelerating the overall market enhancement process throughout the estimated period of 2020-2028. Restraints - Medication and Feeding Errors, Increased Number of Diseases, etc. The continuously rising cases of medication and feeding errors, an increase in the number of critical illnesses, neurological or movement disorders, GI dysfunction, aspiration, refeeding syndrome, nausea and vomiting, skin irritation, diarrhoea, tube dislodgement, and tube blockage are widely obstructing the overall progress of the market worldwide. Opportunities - Home-Based Market Growth with Technological Advancements According to McKinsey, by 2025, $265 billion of traditional healthcare will shift to home-based healthcare services. The shift towards home-based healthcare services presents a significant opportunity for the enteral feeding devices market. Homecare settings provide a cost-effective and comfortable environment for patients to receive enteral nutrition, leading to increased demand for portable and user-friendly feeding devices. Continued technological advancements present opportunities for innovation in enteral feeding devices for home-based usage. There is potential for developing more advanced and user-friendly devices, such as intelligent pumps with integrated monitoring capabilities, wireless communication systems, and improved materials for feeding tubes. These innovations can enhance patient comfort, safety, and ease of use at their home. Integrating Internet of Things (IoT) technology in enteral feeding devices allows for remote monitoring, data collection, and real-time feedback, enabling better management of patient nutrition. Quantex 4C is a cloud-based device that can monitor patients remotely and free up hospital beds, allowing doctors to pre-program devices and collect depersonalized data to improve product, compliance, and user experience. Enteral Feeding Devices Market Analysis of Different Segments Covered in the Report Based on Product Type: Giving set Percutaneous endoscopic gastrostomy device Enteral feeding pumps Low profile gastrostomy device Gastrostomy tube Nasogastric tube Others Based on Age Group: Children Adult Pediatric Based on Applications: Diabetes Cancer Neurological Disorders Others Based on End-User Hospitals ASC (Ambulatory Surgical Centers) Home Care Regional Coverage Analysis North America US Mexico Canada Rest of North America Europe Switzerland Russia France Germany U.K Finland Turkey Netherlands Belgium Spain Italy Rest of Europe Asia Pacific China India Indonesia South Korea Thailand Japan Singapore Malaysia Philippines Australia Rest of Asia-Pacific LAMEA Brazil Saudi Arabia Uruguay Argentina Rest of LAMEA Based on Product Type, ‘Enteral feeding pumps dominated the market in 2020, with an overall market share of 37.51% of the entire global market and is expected to grow at the fastest rate with a CAGR of 6.58% due to the rise in usage among the patients who are lacking vital micronutrients worldwide. Based on Age Group, the ‘Adult’ segment held the largest share in 2020 with, with a CAGR of 6.17%. According to the National Library of Medicine, in 2017, there were 248,846 adult patients and 189,036 pediatric patients, which meant that more than 50% of people with feeding tubes were adults. Lack of proper nutrition and an increase in the difficulty of swallowing food the patients are significantly driving the growth of this segment. Based on Applications, in 2020, the ‘Cancer’ segment dominated the market with a CAGR of 6.897%. According to National Center for Biotechnology Information, in 2020, the total number of cancer cases rose to 19.3 million across the globe, and according to ACS Journals, in the United States, there were 1,806,590 new cancer cases in 2020, where digestive system cancer accounted for the highest number of cases (333,680 or approx.18.47%). Based on End-User, the ‘Hospitals’ segment accounted for the highest market share in 2020 with an overall value of USD 1.77 billion and a total CAGR of 6.61%. The higher rate of utilization of the feeding tubes due to their large availability in the hospitals is driving the growth rate of this segment widely. Based on Regions, North America dominated the market significantly with an overall market share of 33.21% in 2020 due to the rising awareness of the usage of enteral feeding devices and its rate of early approvals. However, the APAC region held the fastest growth rate in this market, with an overall CAGR of 7.13% over the forecasted period. Enteral Feeding Devices Market Competitive Landscape Analysis Competitive Landscape Analysis is widely used to properly identify vital competitors in the market worldwide. The comparison is entirely based on global presence, the expenditure in the field of R&D, company overview and financials, overall revenue generated, market initiatives, production capacity, market capability, production sites and its variety of facilities, organization strengths, and weaknesses, etc. Becton, Dickinson, and Company CONMED Corporation Boston Scientific Corporation Danone S.A. Cardinal Health Inc. Moog Inc. Cook Medical Fresenius Kabi Vygon Group Nestlé S.A. B. Braun Melsungen AG Avanos Medical Inc Baxter International Inc. Amsino International Inc. Omex Medical Technology Applied Medical Technology Danumed Medizintechnik Fuji Systems Corporation Kentec Medical Inc. Medline Industries, Inc. Vesco Medical LLC Medela Inc. Dynarex Corporation Alcor Scientific Recent Developments: In July 2022, Vonco launched its brand new enteral feeding device, EnteraLoc, for which it received the Highest-Achievement award 2022. EnteraLoc is regarded as a type of medical-fluid device that is exclusively intended for the purpose of enteral tube feeding for patients. It was also regarded as the 1st closed-loop solution that combines various nutritional meals with a flexible pouch and directly connects the ENFit device to the enteral-feeding system. On Oct 2019, Fresenius Kabi successfully completed the expansion of its plant for parenteral nutrition in Brazil, thereby increasing the capacity of parenteral nutrition production comprehensively by almost thirty percent. On Apr 2018, B. Braun Medical industries opened 5 new production plants in Malaysia to improve its manufacturing capacities of medical devices for infusion therapy, surgical instruments, and pharmaceutical solutions. The Devices that the Leading Organizations Develop Product Name Function Company Entuit Gastrostomy BR Balloon Retention Feeding Tube Providing gastric access for medication administration, enteral feeding, and decompression through the gastrointestinal stoma tract. Cook Medical Enfit Connector Helps in the reduction of risks that can lead to enteral feeding misconnections. Boston Scientific Corporation Entake PEG System An enteral feeding device that has been specially designed for GI nurses and gastroenterologists who are seeking an initial PEG system that is convenient for usage and will help immensely to improve patient care services. CONMED Corporation Compact Nasogastric Feeding Tube Administration of medications and nutritional fluids into the stomach through the naso-enteric route for patients with an intact gastrointestinal tract but are physically incapable of ingesting enough nutrients orally to meet their present needs. Nestlé Frequently Asked Question About This Report Which is the most dominant region of the market? North America is the most dominant region of the market with an overall share of around 33.213% throughout the forecasted period of 2021-2030. How big is the enteral feeding devices market? The global enteral feeding devices market size was $3.48 Bn in 2021 and is predicted to reach $6.08 Bn by 2030, representing a CAGR of 6.38%. What is the enteral feeding devices market growth? The global enteral feeding devices market is expected to grow at a compound annual growth rate (CAGR) of 6.38% from 2021 to 2030 to reach USD 6.8 billion by 2030. Which is the leading Product Type segment of the market? The leading Product Type segment of the market is the ‘Enteral feeding pumps’, with an overall share of 37.51 % of the entire global market and is expected to grow at the fastest rate with a CAGR of 6.58%. What is the largest application segment of the market? The Cancer segment is the largest application segment of the market with a CAGR of 6.897% in 2020. Who are the leading industry players? Top Industry players of the market are Becton, Dickinson and Company, CONMED Corporation, Boston Scientific Corporation, Danone S.A., Cardinal Health Inc, Moog Inc, Cook Medical, Fresenius Kabi, Vygon Group, Nestlé S.A, B. Braun Melsungen AG, Avanos Medical Inc, Baxter International Inc, Amsino International Inc, Omex Medical Technology, Applied Medical Technology, Danumed Medizintechnik,Fuji Systems Corporation, Kentec Medical Inc, Medline Industries Inc, Vesco Medical LLC, Medela Inc, Dynarex Corporation, Alcor Scientific, etc. What is the largest segment of End-user of the market? Hospital is the largest segment of the market in terms of End-user with an overall value of USD 1.773 billion in 2020 and an overall CAGR of 6.613%. Sources https://pubmed.ncbi.nlm.nih.gov/11877572/ https://www.nutritioncare.org/About_Clinical_Nutrition/What_is_Enteral_Nutrition/ https://nationalhealthcouncil.org/wp-content/uploads/2019/12/NHC_Files/Pdf_Files/AboutChronicDisease.pdf https://www.quantex-arc.com/medical-pharmaceutical-overview/quantex-4c/ https://www.mckinsey.com/industries/healthcare/our-insights/from-facility-to-home-how-healthcare-could-shift-by-2025 https://www.who.int/news-room/fact-sheets/detail/ageing-and-health https://hoist-medical.com/en/avancees-nutrition-enterale/ https://www.cardinalhealth.com/en/product-solutions/medical/enteral-feeding.html https://lanalifecare.com/pros-and-cons-feeding-tubes-for-elderly/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Enteral Feeding Devices Market 4.2.1 Market, 2020 – 2028 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, By Region, 2021 - 2030 (USD Million) 4.4 Product Type Business Analysis 4.4.1 Market, By Product Type, 2021 - 2030 (USD Million) 4.5 Age Group Business Analysis 4.5.1 Market, By Age Group, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 End-User Business Analysis 4.7.1 Market, By End-User, 2021 - 2030 (USD Million) 4.8 Value Chain Analysis 4.9 Market Variable Analysis 4.9.1 Drivers Analysis 4.9.2 Restraints Analysis 4.10 Business Environment Analysis Tool 4.10.1 PEST analysis 4.10.2 Porter’s analysis 4.11 Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Technology Analysis 5.11.1. Trends in Technology (2014-2020) 5.11.2. Trends in Technology (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Country) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Type 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Type Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Giving set 7.3.1. Giving set Market, 2021 - 2030 (USD Million) 7.4. Percutaneous endoscopic gastrostomy device 7.4.1. Percutaneous endoscopic gastrostomy device Market, 2021 - 2030 (USD Million) 7.5. Enteral feeding pumps 7.5.1. Enteral feeding pumps Market, 2021 - 2030 (USD Million) 7.6. Low profile gastrostomy device 7.6.1. Low profile gastrostomy device Market, 2021 - 2030 (USD Million) 7.7. Gastrostomy tube 7.7.1. Gastrostomy tube Market, 2021 - 2030 (USD Million) 7.8. Nasogastric tube 7.7.1. Nasogastric tube Market, 2021 - 2030 (USD Million) 7.9. Others 7.8.1. Others Market, 2021 - 2030 (USD Million) 8. Market: By Age Group Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Children 8.3.1. Children Market, 2021 - 2030 (USD Million) 8.4. Adult 8.4.1. Adult Market, 2021 - 2030 (USD Million) 8.5. Pediatric 8.5.1. Pediatric Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Diabetes 9.3.1. Diabetes Market, 2021 - 2030 (USD Million) 9.4. Cancer 9.4.1. Cancer Market, 2021 - 2030 (USD Million) 9.5 Neurological Disorders 9.5.1 Neurological Disorders Market, 2021 - 2030 (USD Million) 9.6. Others 9.6.1. Others Market, 2021 - 2030 (USD Million) 10. Market: By End-User Segment Analysis 10.1. Introduction 10.2. Sales Volume & Revenue Analysis (2021-2030) 10.3. Hospitals 10.3.1. Hospitals Market, 2021 - 2030 (USD Million) 10.4. ASC (Ambulatory Surgical Centers) 10.4.1. ASC (Ambulatory Surgical Centers) Market, 2021 - 2030 (USD Million) 10.5 Home Care 10.5.1 Home Care Market, 2021 - 2030 (USD Million) 11. Market: Regional Outlook 11.1 North America 11.1.1. North America Market, By Product Type, 2021 - 2030 (USD Million) 11.1.2. North America Market, By Age Group, 2021 - 2030 (USD Million) 11.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 11.1.4. North America Market, By End-User, 2021 - 2030 (USD Million) 11.1.5. North America Market, by Country, 2021 - 2030 (USD Million) 11.1.4.1. U.S. 11.1.4.1.1. U.S. Market, By Product Type, 2021 - 2030 (USD Million) 11.1.4.1.2. U.S. Market, By Age Group, 2021 - 2030 (USD Million) 11.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 11.1.4.2. Canada 11.1.4.2.1. Canada Market, By Product Type, 2021 - 2030 (USD Million) 11.1.4.2.2. Canada Market, By Age Group, 2021 - 2030 (USD Million) 11.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 11.2. Europe 11.2.1. Europe Market, By Product Type, 2021 - 2030 (USD Million) 11.2.2. Europe Market, by By End-User, 2021 - 2030 (USD Million) 11.2.3. Europe Market, By Age Group, 2021 - 2030 (USD Million) 11.2.4. Europe Market, by Application, 2021 - 2030 (USD Million) 11.2.5. Europe Market, by country, 2021 - 2030 (USD Million) 11.2.4.1 U.K. 11.2.4.1.1. U.K. Market, By Product Type, 2021 - 2030 (USD Million) 11.2.4.1.2. U.K. Market, By Age Group, 2021 - 2030 (USD Million) 11.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 11.2.4.2. Germany 11.2.4.2.1. Germany Market, By Product Type, 2021 - 2030 (USD Million) 11.2.4.2.2. Germany Market, By Age Group, 2021 - 2030 (USD Million) 11.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 11.2.4.3. France 11.2.4.3.1. France Market, By Product Type, 2021 - 2030 (USD Million) 11.2.4.3.2. France Market, By Age Group, 2021 - 2030 (USD Million) 11.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 11.2.4.4. Rest of Europe 11.2.4.4.1. Rest of Europe Market, By Product Type, 2021 - 2030 (USD Million) 11.2.4.4.2. Rest of Europe Market, By Age Group, 2021 - 2030 (USD Million) 11.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 11.3. Asia Pacific 11.3.1. Asia Pacific Market, By Product Type, 2021 - 2030 (USD Million) 11.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 11.3.3. Asia Pacific Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 11.3.5. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 11.3.4.1. China 11.3.4.1.1. China Market, By Product Type, 2021 - 2030 (USD Million) 11.3.4.1.2. China Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 11.3.4.2. India 11.3.4.2.1. India Market, By Product Type, 2021 - 2030 (USD Million) 11.3.4.2.2. India Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 11.3.4.3. Japan 11.3.4.3.1. Japan Market, By Product Type, 2021 - 2030 (USD Million) 11.3.4.3.2. Japan Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 11.3.4.4. South Korea 11.3.4.4.1. South Korea Market, By Product Type, 2021 - 2030 (USD Million) 11.3.4.4.2. South Korea Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 11.3.4.5. Rest of ASIA PACIFIC 11.3.4.5.1. Rest of ASIA PACIFIC Market, By Product Type, 2021 - 2030 (USD Million) 11.3.4.5.2. Rest of ASIA PACIFIC Market, By Age Group, 2021 - 2030 (USD Million) 11.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 11.4. Latin America 11.4.1. Latin America Market, By Product Type, 2021 - 2030 (USD Million) 11.4.2. Latin America Market, By Age Group, 2021 - 2030 (USD Million) 11.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 11.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 11.4.4.1. Brazil 11.4.4.1.1. Brazil Market, By Product Type, 2021 - 2030 (USD Million) 11.4.4.1.2. Brazil Market, By Age Group, 2021 - 2030 (USD Million) 11.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 11.4.4.2. Mexico 11.4.4.2.1. Mexico Market, By Product Type, 2021 - 2030 (USD Million) 11.4.4.2.2. Mexico Market, By Age Group, 2021 - 2030 (USD Million) 11.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 11.4.4.3. Rest of the Latin America 11.4.4.3.1. Rest of the Latin America Market, By Product Type, 2021 - 2030 (USD Million) 11.4.4.3.2. Rest of the Latin America Market, By Age Group, 2021 - 2030 (USD Million) 11.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 11.5. MEA 11.5.1. MEA Market, By Product Type, 2021 - 2030 (USD Million) 11.5.2. MEA Market, By Age Group, 2021 - 2030 (USD Million) 11.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 11.5.4. MEA Market, By End-User, 2021 - 2030 (USD Million) 12. Competitive Landscape 12.1 Becton, Dickinson, and Company. 12.1.1. Company overview 12.1.2. Financial performance 12.1.3. Product Portfolio Analysis 12.1.4. Business Strategy & Recent Development 12.2. CONMED Corporation. 12.2.1. Company overview 12.2.2. Financial performance 12.2.3. Product Portfolio Analysis 12.2.4. Business Strategy & Recent Development 12.3. Boston Scientific Corporation. 12.3.1. Company overview 12.3.2. Financial performance 12.3.3. Product Portfolio Analysis 12.3.4. Business Strategy & Recent Development 12.4. Danone S.A. 12.4.1. Company overview 12.4.2. Financial performance 12.4.3. Product Portfolio Analysis 12.4.4. Business Strategy & Recent Development 12.5. Cardinal Health Inc. 12.5.1. Company overview 12.5.2. Financial performance 12.5.3. Product Portfolio Analysis 12.5.4. Business Strategy & Recent Development 12.6. Moog Inc. 12.6.1. Company overview 12.6.2. Financial performance 12.6.3. Product Portfolio Analysis 12.6.4. Business Strategy & Recent Development 12.7. Cook Medical. 12.7.1. Company overview 12.7.2. Financial performance 12.7.3. Product Portfolio Analysis 12.7.4. Business Strategy & Recent Development 12.8. Fresenius Kabi. 12.8.1. Company overview 12.8.2. Financial performance 12.8.3. Product Portfolio Analysis 12.8.4. Business Strategy & Recent Development 12.9. Vygon Group. 12.9.1. Company overview 12.9.2. Financial performance 12.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 12.10. Nestlé S.A. 12.10.1. Company overview 12.10.2. Financial performance 12.10.3. Product Portfolio Analysis 12.10.4. Business Strategy & Recent Development 12.11. B. Braun Melsungen AG. 12.11.1. Company overview 12.11.2. Financial performance 12.11.3. Product Portfolio Analysis 12.11.4. Business Strategy & Recent Development 12.12. Avanos Medical Inc. 12.12.1. Company overview 12.12.2. Financial performance 12.12.3. Product Portfolio Analysis 12.12.4. Business Strategy & Recent Development 12.13. Baxter International Inc. 12.13.1. Company overview 12.13.2. Financial performance 12.13.3. Product Portfolio Analysis 12.13.4. Business Strategy & Recent Development 12.14. Amsino International Inc. 12.14.1. Company overview 12.14.2. Financial performance 12.14.3. Product Portfolio Analysis 12.14.4. Business Strategy & Recent Development 12.15. Omex Medical Technology. 12.15.1. Company overview 12.15.2. Financial performance 12.15.3. Product Portfolio Analysis 12.15.4. Business Strategy & Recent Development 12.16. Applied Medical Technology . 12.16.1. Company overview 12.16.2. Financial performance 12.16.3. Product Portfolio Analysis 12.16.4. Business Strategy & Recent Development 12.17. Danumed Medizintechnik. 12.17.1. Company overview 12.17.2. Financial performance 12.17.3. Product Portfolio Analysis 12.17.4. Business Strategy & Recent Development 12.18. Fuji Systems Corporation. 12.18.1. Company overview 12.18.2. Financial performance 12.18.3. Product Portfolio Analysis 12.18.4. Business Strategy & Recent Development 12.19. Kentec Medical Inc. 12.19.1. Company overview 12.19.2. Financial performance 12.19.3. Product Portfolio Analysis 12.19.4. Business Strategy & Recent Development 12.20. Medline Industries, Inc. 12.20.1. Company overview 12.20.2. Financial performance 12.20.3. Product Portfolio Analysis 12.20.4. Business Strategy & Recent Development 12.21. Vesco Medical LLC. 12.21.1. Company overview 12.21.2. Financial performance 12.21.3. Product Portfolio Analysis 12.21.4. Business Strategy & Recent Development 12.22. Medela Inc. 12.22.1. Company overview 12.22.2. Financial performance 12.22.3. Product Portfolio Analysis 12.22.4. Business Strategy & Recent Development 12.23. Dynarex Corporation. 12.23.1. Company overview 12.23.2. Financial performance 12.23.3. Product Portfolio Analysis 12.23.4. Business Strategy & Recent Development 12.24. Alcor Scientific. 12.24.1. Company overview 12.24.2. Financial performance 12.24.3. Product Portfolio Analysis 12.24.4. Business Strategy & Recent Development List of Tables (87 Tables) TABLE 1. MARKET, By Product Type, 2021-2030 (USD Million) TABLE 2. MARKET FOR Giving set, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Percutaneous endoscopic gastrostomy device, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Enteral feeding pumps, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET FOR Low profile gastrostomy device, BY REGION, 2021-2030 (USD Million) TABLE 6. MARKET FOR Gastrostomy tube, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Nasogastric tube, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET, By Age Group, 2021-2030 (USD Million) TABLE 10. MARKET FOR Children, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET FOR Adult, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET FOR Pediatric, BY REGION, 2021-2030 (USD Million) TABLE 12. MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Diabetes, BY REGION, 2021-2030 (USD Million) TABLE 14. MARKET FOR Cancer, BY REGION, 2021-2030 (USD Million) TABLE 15. MARKET FOR Neurological Disorders, BY REGION, 2021-2030 (USD Million) TABLE 16. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 17. MARKET, BY End-User, 2021-2030 (USD Million) TABLE 18. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 19. MARKET FOR ASC (Ambulatory Surgical Centers), BY REGION, 2021-2030 (USD Million) TABLE 20. MARKET FOR Home Care, BY REGION, 2021-2030 (USD Million) TABLE 21. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 23. NORTH AMERICA MARKET, BY End-Users, 2021-2030 (USD Million) TABLE 24. NORTH AMERICA MARKET, By Product Type, 2021-2030 (USD Million) TABLE 25. NORTH AMERICA MARKET, By Age Group, 2021-2030 (USD Million) TABLE 26. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 27. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. EUROPE MARKET, By Product Type, 2021-2030 (USD Million) TABLE 29. EUROPE MARKET, By End-Users, 2021-2030 (USD Million) TABLE 30. EUROPE MARKET, By Age Group, 2021-2030 (USD Million) TABLE 31. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 32. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. ASIA-PACIFIC MARKET, By Product Type, 2021-2030 (USD Million) TABLE 34. ASIA-PACIFIC MARKET, By Age Group, 2021-2030 (USD Million) TABLE 35. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 36. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 37. LAMEA MARKET, By Product Type, 2021-2030 (USD Million) TABLE 38. LAMEA MARKET, By Age Group, 2021-2030 (USD Million) TABLE 39. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million) TABLE 40. Becton, Dickinson, and Company: COMPANY SNAPSHOT TABLE 41. Becton, Dickinson, and Company: OPERATING SEGMENTS TABLE 42. CONMED Corporation: COMPANY SNAPSHOT TABLE 43. CONMED Corporation: OPERATING SEGMENTS TABLE 44. Boston Scientific Corporation: COMPANY SNAPSHOT TABLE 45. Boston Scientific Corporation: OPERATING SEGMENTS TABLE 46. Danone S.A.: COMPANY SNAPSHOT TABLE 47. Danone S.A.: OPERATING SEGMENTS TABLE 48. Cardinal Health Inc: COMPANY SNAPSHOT TABLE 49. Cardinal Health Inc: OPERATING SEGMENTS TABLE 50. Moog Inc.: COMPANY SNAPSHOT TABLE 51. Moog Inc.: OPERATING SEGMENTS TABLE 52. Cook Medical: COMPANY SNAPSHOT TABLE 53. Cook Medical: OPERATING SEGMENTS TABLE 54. Fresenius Kabi: COMPANY SNAPSHOT TABLE 55. Fresenius Kabi: OPERATING SEGMENTS TABLE 56. Vygon Group: COMPANY SNAPSHOT TABLE 57. Vygon Group: OPERATING SEGMENTS TABLE 58. Nestlé S.A.: COMPANY SNAPSHOT TABLE 59. Nestlé S.A.: OPERATING SEGMENTS TABLE 60. B. Braun Melsungen AG.: COMPANY SNAPSHOT TABLE 61. B. Braun Melsungen AG.: OPERATING SEGMENTS TABLE 62. Avanos Medical Inc.: COMPANY SNAPSHOT TABLE 63. Avanos Medical Inc.: OPERATING SEGMENTS TABLE 64. Baxter International Inc: COMPANY SNAPSHOT TABLE 65. Baxter International Inc: OPERATING SEGMENTS TABLE 66. Amsino International Inc.: COMPANY SNAPSHOT TABLE 67. Amsino International Inc.: OPERATING SEGMENTS TABLE 68. Omex Medical Technology: COMPANY SNAPSHOT TABLE 69. Omex Medical Technology: OPERATING SEGMENTS TABLE 70. Applied Medical Technology: COMPANY SNAPSHOT TABLE 71. Applied Medical Technology: OPERATING SEGMENTS TABLE 72. Danumed Medizintechnik : COMPANY SNAPSHOT TABLE 73. Danumed Medizintechnik: OPERATING SEGMENTS TABLE 74. Fuji Systems Corporation: COMPANY SNAPSHOT TABLE 75. Fuji Systems Corporation: OPERATING SEGMENTS TABLE 76. Kentec Medical Inc.: COMPANY SNAPSHOT TABLE 77. Kentec Medical Inc.: OPERATING SEGMENTS TABLE 78. Medline Industries, Inc.: COMPANY SNAPSHOT TABLE 79. Medline Industries, Inc.: OPERATING SEGMENTS TABLE 80. Vesco Medical LLC.: COMPANY SNAPSHOT TABLE 81. Vesco Medical LLC.: OPERATING SEGMENTS TABLE 82. Medela Inc.: COMPANY SNAPSHOT TABLE 83. Medela Inc.: OPERATING SEGMENTS TABLE 84. Dynarex Corporation: COMPANY SNAPSHOT TABLE 85. Dynarex Corporation: OPERATING SEGMENTS TABLE 86. Alcor Scientific: COMPANY SNAPSHOT TABLE 87. Alcor Scientific: OPERATING SEGMENTS List of Figures (24 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 24 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Enteral Feeding Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Enteral Feeding Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By Age Group, 2019 vs. 2025 (USD Million) Figure 12 Market, By End-Users, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Application, 2019 vs. 2025 Figure 14 Market Share, By Product Type, 2019 vs. 2025 Figure 15 Geographical Snapshot of the Market Figure 16 Adult to Witness Higher CAGR in Market for Age Group Segment during Forecast Period. Figure 17 Enteral feeding pumps to Witness Higher CAGR in Market for Product Type Segment during Forecast Period. Figure 18 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 19 Cancer to Witness Higher CAGR in Market for Applications Segment during Forecast Period. Figure 20 North America Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 21 Market: Drivers, Restraints, Opportunities, and Challenges Figure 22 North America: Market Snapshot Figure 23 Asia Pacific: Market Snapshot Figure 24 Vendor Dive: Evaluation Overview